Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07223047
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+1 more
Bristol-Myers Squibb 252
Early research (Phase 1)Looking for participantsNCT06867497
What this trial is testing

Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Boryung Pharmaceutical Co., Ltd 20
Testing effectiveness (Phase 2)Study completedNCT03415854
What this trial is testing

Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Adenocarcinoma+2 more
HonorHealth Research Institute 34
Very early researchStudy completedNCT02896907
What this trial is testing

Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 8
Early research (Phase 1)Study completedNCT00981162
What this trial is testing

Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Roswell Park Cancer Institute 12
Not applicableEnded earlyNCT02494388
What this trial is testing

Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions

Who this might be right for
Pancreatic CystsPancreatic Mucinous-Cystic NeoplasmIntraductal Papillary Mucinous Neoplasm+3 more
University of Medicine and Pharmacy Craiova 10
Early research (Phase 1)Looking for participantsNCT07594964
What this trial is testing

To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors

Who this might be right for
Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)Pancreatic Ductal Adenocarcinoma (PDAC)Hepatocellular Carcinoma (HCC)+1 more
Shenzhen Xinhe Biomedical 48
Testing effectiveness (Phase 2)WithdrawnNCT04058964
What this trial is testing

Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00116389
What this trial is testing

Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerNeoplasm MetastasisAdenocarcinoma
Point Therapeutics 60
Early research (Phase 1)Study completedNCT01473940
What this trial is testing

Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Duct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+1 more
Northwestern University 21
Not applicableStudy completedNCT03105921
What this trial is testing

Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaInterventional Imaging
Poitiers University Hospital 20
Not applicableStudy completedNCT00936104
What this trial is testing

Side Population in Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
NeoplasmPancreas
University Hospital, Gasthuisberg 20
Early research (Phase 1)Ended earlyNCT02908451
What this trial is testing

AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+1 more
AbGenomics B.V Taiwan Branch 39
Early research (Phase 1)Study completedNCT02021422
What this trial is testing

A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy

Who this might be right for
Pancreas Cancer
Baylor Research Institute 13
Early research (Phase 1)Looking for participantsNCT07360314
What this trial is testing

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
EMD Serono Research & Development Institute, Inc. 138
Not applicableUnknownNCT04605237
What this trial is testing

Pancreatic Cancer Recurrence in the Netherlands

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreas Cancer+1 more
UMC Utrecht 1,750
Testing effectiveness (Phase 2)Study completedNCT01472198
What this trial is testing

Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Gilead Sciences 250
Testing effectiveness (Phase 2)Looking for participantsNCT06885034
What this trial is testing

Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

Who this might be right for
Gastrointestinal Neoplasms
GlaxoSmithKline 451
Early research (Phase 1)Active Not RecruitingNCT06447662
What this trial is testing

Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsCarcinoma, Non-Small-Cell Lung
Pfizer 64
Early research (Phase 1)Study completedNCT01893294
What this trial is testing

Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Duct Cell Adenocarcinoma of the PancreasStage III Pancreatic CancerStage IV Pancreatic Cancer
Mayo Clinic 1
Next Page